FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Delayed Deutsche Boerse AG 12:06:05 2024-05-14 pm EDT | ||
| 0.09 EUR | -10.00% |
|
| Current month | +33.33% | ||
| 1 month | +104.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-14 | 0.09 | -10.00% |
| 24-05-13 | 0.1 | 0.00% |
| 24-05-10 | 0.1 | +11.11% |
| 24-05-09 | 0.09 | 0.00% |
| 24-05-08 | 0.09 | +7.14% |
Delayed Quote Deutsche Boerse AG
Last update May 14, 2024 at 12:06 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SH3NJ7 |
| ISIN | DE000SH3NJ78 |
| Date issued | 2022-03-07 |
| Strike | 211.3 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.36 € |
|---|---|
| Lowest since issue | 0.032 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
225.3
USD
Average target price
285.9
USD
Spread / Average Target
+26.88%
- Stock Market
- Certificates
- Certificat